SpringWorks Therapeutics Inc
NASDAQ:SWTX

Watchlist Manager
SpringWorks Therapeutics Inc Logo
SpringWorks Therapeutics Inc
NASDAQ:SWTX
Watchlist
Price: 46.99 USD 0.02% Market Closed
Market Cap: 3.5B USD

Wall Street
Price Targets

SWTX Price Targets Summary
SpringWorks Therapeutics Inc

There are no price targets for SWTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
SpringWorks Therapeutics Inc Competitors:
Price Targets
FYB
Formycon AG
102% Upside
ATX
Amplia Therapeutics Ltd
257% Upside
BIOCON
Biocon Ltd
11% Upside
9926
Akeso Inc
54% Upside
ATRA
Atara Biotherapeutics Inc
15% Upside
DVAX
Dynavax Technologies Corp
90% Upside
NRIX
Nurix Therapeutics Inc
47% Upside
ALT
Altimmune Inc
370% Upside

Revenue
Forecast

Revenue Estimate
SpringWorks Therapeutics Inc

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 61%.

N/A
Past Growth
61%
Estimated Growth
Estimates Accuracy
95%
Average Beat

Operating Income
Forecast

Operating Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SWTX's stock price target?
Not Available

SWTX doesn't have any price targets made by Wall Street professionals.

What is SpringWorks Therapeutics Inc's Revenue forecast?
Projected CAGR
61%

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 61%.

Back to Top